Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04073381 · ClinicalTrials.gov registry record · Early Phase 1
Application of Ergogenic Aids to the Prehabilitation of Abdominal Cancer Patients Undergoing Cancer Surgery
A Early Phase 1 study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 92
- Enrollment target
NCT04073381: Completed Early Phase 1 study, sponsored by University of Texas at Austin.
NCT04073381 is a Early Phase 1 study that has completed, run by University of Texas at Austin. The registered enrollment target is 92 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (74% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04073381, a Early Phase 1 study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 92 participants
- Enrollment target
Study Summary
The purpose of the proposed study is to measure surgical recovery, including the length of hospital stay, incidence of perioperative complications, and mortality at 90 days post-surgery, in surgical patients with abdominal cancer. The investigators hypothesize that this prehabilitation program will improve recovery and reduce perioperative complications via the proposed prehabilitation intervention.
Primary Outcome
Length of hospital stay
Interventions
- COMBINATION_PRODUCT Prehabilitation Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2018-10-28 |
| Est. Completion | 2020-08-31 |
| Phase | Early Phase 1 |
What the finished NCT04073381 record still lists
NCT04073381 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (74% higher).
The record links to 0 conditions, and to 1 intervention - of which Prehabilitation Program is the first listed.
NCT04073381 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04073381 about?
NCT04073381 is a clinical study titled "Application of Ergogenic Aids to the Prehabilitation of Abdominal Cancer Patients Undergoing Cancer Surgery". The purpose of the proposed study is to measure surgical recovery, including the length of hospital stay, incidence of perioperative complications, and mortality at 90 days post-surgery, in surgical patients with abdominal cancer. The investigators hypothesize that this prehabilitation program will ...
What is the current status of trial NCT04073381?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 92 participants. The study started on 2018-10-28. Estimated completion is 2020-08-31.
What interventions are being tested in trial NCT04073381?
The interventions under investigation include: Prehabilitation Program (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04073381?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04073381's enrollment target sits among peer trials
92 229th of 2000 higher than 1,769 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI